CML HealthCare Income Fund Provides Update on U.S. Medical Imaging Acquisition Activity
In addition to these acquisitions, CML has entered into a joint venture agreement with Upper Chesapeake Health System ("UCHS") to operate a multi-modality medical imaging center in Bel Air, Maryland. This new facility was opened on
"We are pleased to execute on our stated strategy of growing our U.S. medical imaging business through 'tuck-in' acquisitions in the U.S. Northeast region," said
"While the Quarry Lake acquisition and the UCHS joint venture are smaller in scope, they are both important transactions in our key Maryland network," continued
The Imaging Institute and Quarry Lake Acquisition Details --------------------------------------------------------- Revenues(2) for the twelve months ended August 31, 2009 (unaudited) of TII (Rhode Island) and Quarry Lake (Maryland), as well as the aggregate consideration paid, are included in the following summary: Number of Clinics Six Modalities MRI, CT, Digital Mammography, Ultrasound, X-ray, Bone Densitometry (DEXA) Revenues(2) (unaudited): US$14.3 million Consideration: US$12.3 million, including cash and assumption of capital leases, excluding transaction costs
EBITDA(3) margins (unaudited) of the combined businesses for the same period are in excess of 20%.
The Imaging Institute
TII consists of five fully digital medical imaging centers in the Providence region of Rhode Island with an integrated RIS/PACS system for remote reading and consultation by physicians. The staff radiologists, including
Quarry Lake is a 5,000 square foot dual-modality imaging center located within an eight mile radius of three American Radiology Services, Inc. ("ARS") centers. The center is strategically located to take advantage of increased MRI and CT demand at ARS' existing locations.
UCHS Joint Venture ------------------
UCHS, established in 1984, is a not-for-profit health organization and the exclusive acute care provider in Harford County, Maryland and includes two hospitals: Upper Chesapeake Medical Center ("UCMC") in Bel Air and Harford Memorial Hospital in Havre de Grace. The new medical imaging center, Upper Chesapeake Health Imaging Center/American Radiology Services, developed as a joint venture with UCHS, is a 10,000 square foot, multi-modality center (including MRI, CT, Digital Mammography, Ultrasound, X-ray, DEXA) that will provide patients with a convenient, off-campus, out-patient facility within one mile of UCMC. The service offering to patients and referring physicians should be seamless as ARS holds the hospital radiology contract at Harford Memorial Hospital and each of ARS and UCHS hold a 50% interest in the new joint venture entity.
(1) Distributable Cash of the Fund is not a Canadian generally accepted accounting principle ("GAAP") measure, and though it is generally used by Canadian open-ended trusts as an indicator of financial performance, it should not be seen as a measure of liquidity or a substitute for comparable metrics prepared in accordance with GAAP. One characteristic of certain non-GAAP measures such as Distributable Cash is the inclusion of management's adjustments for entity-specific issues not contemplated in a standard measurement, such as Standardized Distributable Cash that focuses on comparability across entities and consistency over time. Therefore, the Fund's Distributable Cash may differ from similar calculations as reported by other similar entities and, accordingly, may not be comparable to Distributable Cash as reported by such entities. The Fund's objective for disclosing the Distributable Cash calculation is to outline the net cash flow generated by the Fund that was available for distribution during the period and anticipated to be sustainable into the next period. The Fund uses Distributable Cash to evaluate, on a consistent basis, sustainable cash generated from its operations, and to evaluate cash available for distributions. (2) Revenues are net of professional services costs in the case of TII. (3) The Fund defines EBITDA as earnings before interest, taxes, depreciation, amortization, other expenses, non-controlling interest, gain/loss on disposals of property and equipment, foreign exchange gain and transaction costs on debt financing. EBITDA margins are calculated by dividing EBITDA by revenues. EBITDA is not a recognized measure under Canadian GAAP. Management believes that, in addition to net earnings, EBITDA is a useful supplemental measure, as it provides investors with an indication of the Fund's performance. EBITDA is used by the Fund to analyze performance and compare profitability between periods. Investors should be cautioned, however, that EBITDA should not be construed as an alternative to net earnings determined in accordance with GAAP. The Fund's method of calculating EBITDA may differ from other companies or income trusts and, accordingly, EBITDA may not be comparable to measures used by other companies or income trusts.
About CML HealthCare Income Fund
CML HealthCare Income Fund is an unincorporated open-ended trust that owns CML HealthCare Inc., one of Canada's largest healthcare services businesses. Based in Mississauga, Ontario, CML HealthCare Inc. is a leading provider of laboratory testing services in Ontario and the largest private provider of medical imaging services in
Caution concerning forward-looking statements
Statements made in this news release, other than those concerning historical financial information, may be forward-looking and therefore subject to various risks and uncertainties. Some forward-looking statements may be identified by words like "may", "will", "anticipate", "estimate", "expect", "intend", or "continue" or the negative thereof or similar variations. Readers are cautioned not to place undue reliance on such statements, as actual results may differ materially from those expressed or implied in such statements. Factors that could cause results to vary include, but are not limited to: dependence on government-based revenues; pending and proposed legislative or regulatory developments including the impact of changes in laws, regulations and the enforcement thereof; intensifying competition from established competitors and new entrants in the businesses in which we operate; technological change; interest rate fluctuations and general economic conditions; insurance coverage of sufficient scope to satisfy any liability claims; fluctuations in operating results; dependence on our ability to renegotiate the MOH contract on favourable terms; dependence on our operating subsidiary to pay its interest obligations; fluctuations in cash distributions and capital investment; management of credit, market, liquidity and funding and operational risks; judicial judgments and legal proceedings; our ability to complete strategic acquisitions and to integrate our acquisitions successfully; changes in accounting policies and methods we use to report our financial condition, including uncertainties associated with critical accounting assumptions and estimates; operational and infrastructure risks including possible equipment failure and performance of information technology systems; fluctuations in total patient referrals; loss of services of key senior management personnel; other factors that may affect future growth and results including, timely development and introduction of new products and services; changes in our estimates relating to reserves and allowances; future sales of units; changes in tax laws; technological changes and obsolescence, natural disasters, the possible impact on our businesses from public health emergencies, international conflicts and other developments including those relating to terrorism; the effect of anyone or more of such events and risks on our stability ratings and any changes thereto; and our success in anticipating and managing the foregoing risks. Additional factors related to the acquisition of American Radiology Services, Inc. ("ARS") include, but are not limited to, the Fund's ability to successfully integrate the operations of ARS, additional liabilities or costs attributable to the acquisition of ARS, unknown liabilities of ARS, the ability to retain senior management of ARS, the ability to complete accretive acquisitions in the U.S., the continuation and nature of the relationship with The Johns Hopkins University and The Johns Hopkins Health System Corporation (collectively "Johns Hopkins") and changes in U.S. federal and state healthcare laws and regulations, including with respect to Medicare and Medicaid reimbursements levels.
We caution that the foregoing list of factors is not exhaustive and that when reviewing our forward-looking statements investors and others should refer to the "Risk Factors" section of the Fund's Annual Information Form, the "Risks and Uncertainties" and other sections of our Management's Discussion and Analysis of Operating Results and Financial Position and our other periodic filings with Canadian securities regulatory authorities. All forward-looking statements presented herein should be considered in conjunction with such filings. Except as required by Canadian securities law, we do not undertake to update any forward-looking statements, whether written or oral, that may be made from time to time by us or on our behalf; such statements speak only as of the date made.For further information: Bruce Wigle or Alice Dunning, Investor Relations, The Equicom Group Inc., (416) 815-0700 ext 228 or ext 255, (416) 815-0080 fax, Email: email@example.com or firstname.lastname@example.org; Tom Weber, Chief Financial Officer, CML HealthCare Income Fund, (905) 565-0043, (905) 565-1776 fax, Internet: www.cmlhealthcare.com